**Core Concept:** Metoprolol is a selective beta-blocker that inhibits the binding of catecholamines to beta-adrenergic receptors. In children, metoprolol is used to treat congenital heart defects and supraventricular tachycardia due to its ability to reduce heart rate and contractility.

**Why the Correct Answer is Right:** Metoprolol is a beta-blocker, which primarily affects the cardiovascular system. In children, its primary indication is for treating heart defects and supraventricular tachycardia, both of which involve the heart. In the context of this question, the correct answer should be related to a condition that is less likely to be the presenting concern or effect of metoprolol administration in a 3-year-old child.

**Why Each Wrong Option is Incorrect:**

A. **Diabetic ketoacidosis (DKA):** Metoprolol does not cause or worsen DKA, making it an unlikely condition in a child taking metoprolol.

B. **Pneumonia:** While pneumonia can present with respiratory symptoms, metoprolol does not directly affect the respiratory system, making it an unlikely condition in a child on metoprolol therapy.

C. **Asthma:** Metoprolol does not affect asthma symptoms or exacerbation, making it less likely to present as the condition in a child on metoprolol therapy.

D. **Anaphylactic shock:** Anaphylactic shock is a severe allergic reaction that is unrelated to beta-blockers like metoprolol. Therefore, metoprolol administration is less likely to cause anaphylactic shock in a child.

**Clinical Pearl:** It is essential to consider the specific medication and its intended effects while diagnosing and treating a patient, particularly when assessing for adverse reactions or complications. In this case, metoprolol is unlikely to cause the mentioned conditions (DKA, pneumonia, asthma, and anaphylactic shock) due to its pharmacological properties and primary indications.